DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Seletracetam is an investigational drug.
There have been 5 clinical trials for Seletracetam. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2006.
The most common disease conditions in clinical trials are Epilepsy, Seizures, and Epilepsies, Partial. The leading clinical trial sponsors are UCB Pharma and [disabled in preview].
Recent Clinical Trials for Seletracetam
|Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy||UCB Pharma||Phase 3|
|A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures||UCB Pharma||Phase 2/Phase 3|
|Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.||UCB Pharma||Phase 3|